-
Mashup Score: 1North American Conference on Lung Cancer 2023 Preview | IASLC - 7 month(s) ago
In this episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu preview the 2023 North America Conference on Lung Cancer, scheduled for …
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Artificial Intelligence and Pathology | IASLC - 9 month(s) ago
Artificial intelligence is one of the most significant trends in most parts of society. Increasingly, oncologists and lung cancer researchers are including AI a …
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Increasingly, oncologists & #lungcancer researchers are including AI as part of their research/patient care; @NarjustFlorezMD leads a discussion of this compelling technology, its promise & limitations w/guests Drs. Sanja Dacic & Fabio Ynoe de Moraes:https://t.co/BKlA0GacvN #LCSM https://t.co/5QnU6uHesn
-
-
Mashup Score: 4iMig 2023 Highlights | IASLC - 9 month(s) ago
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses some of the highlights from iMig 2023 – the International Mesothelioma Interest Grou …
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this #LungCancerConsidered episode, host @StephenVLiu discusses highlights from @imig2023, held in late June 2023 in Lille, France with guests @ScherpereelA, and Dr. Jan van Meerbeeck. Listen Now: https://t.co/Uw9gIoMHim #LCSM https://t.co/ZnSsKzmQN1
-
-
Mashup Score: 1EGFR Exon 20 Insertions in NSCLC | IASLC - 10 month(s) ago
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on a specific subset of lung cancer: EGFR exon 20 insertion NSCLC. Joining th …
Source: IASLCCategories: Hem/Oncs, Latest HeadlinesTweet-
For more on this subset of lung cancer, be sure to listen to this episode of Lung Cancer Considered, the @IASLC podcast, where I discuss #EGFR exon 20 insertion NSCLC with Dr. Byoung Cho, Dr. Rosario Campelo @charocampelo and Marcia Horn @Exon20Group. https://t.co/i16OujxoC7
-
-
Mashup Score: 02023 Hot Topic in Basic & Translational Science: Resistance to IO in NSCLC | IASLC - 10 month(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
It's time to get informed and inspired! #Immunotherapy researchers, clinicians & students are invited to attend #IO23. Explore the latest critical breakthroughs and learn from keynote Dr. Drew Pardoll of @BloombergKimmel. Don't miss it! Register: https://t.co/Hi9hCIX3DE #LCSM https://t.co/MNiXXaqdAO
-
-
Mashup Score: 32023 Hot Topic in Basic & Translational Science: Resistance to IO in NSCLC | IASLC - 10 month(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Abstract Submission Extension #IO23! Submit your Abstract by 8/18 to showcase your research & contribute to discussions that will shape treatments in #lungcancer. Gain international visibility while networking & collaborating with colleagues. Submit Now: https://t.co/Hi9hCIXBtc https://t.co/L8RpEgJVJq
-
-
Mashup Score: 02023 Hot Topic in Basic & Translational Science: Resistance to IO in NSCLC | IASLC - 10 month(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Abstract Submission Extension #HTIO23! Submit your Abstract by 8/18 to showcase your research & contribute to discussions that will shape treatments in #lungcancer. Gain international visibility while networking & collaborating with colleagues. Submit Now: https://t.co/Hi9hCIXBtc https://t.co/lcDAtZogxJ
-
-
Mashup Score: 02023 Hot Topic in Basic & Translational Science: Resistance to IO in NSCLC | IASLC - 10 month(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The #IO23 Meeting Co-Chairs invite you to attend this exciting event Nov. 10-12, 2023. With Keynote Speakers, opportunity for discussion/networking, & Poster Session. Educational sessions topic areas were recently announced! Learn More & Register: https://t.co/Hi9hCIX3DE #LCSM https://t.co/vG5Km8VgHx
-
-
Mashup Score: 32023 ASCO Highlights | IASLC - 10 month(s) ago
IASLCs Education Committee will present a one-hour live session, synthesizing lung cancer research presented at the recent June meeting of the American Society …
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The @IASLC's Education Committee will present a 1hr live session synthesizing #lungcancer research presented at #ASCO23 to address clinicians need to keep abreast of current research & future trends. Register: https://t.co/InLv3T3zwf @HHorinouchi @JPatelMD @ns_chd @stephanieplsaw https://t.co/DKHDK4tVzr
-
-
Mashup Score: 02023 IASLC CT Screening Symposium | IASLC - 10 month(s) ago
The CT Screening Symposium is a one-day, immersive, in-person event being featured at WCLC 2023 focused on lung cancer screening technologies and best practices …
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
REGISTER NOW! The #CTSS23 Chairs invite you to this 1-day immersive, in-person event being featured at #WCLC23 focused on #lungcancer screening tech & best practices. #CTSS23 will use a mix of live educational presentations, expert discussions, & live Q&A. https://t.co/fowhVmnufJ https://t.co/hEqYUPxSQC
-
Hosts @NarjustFlorezMD & @StephenVLiu preview the #NACLC23 (Dec. 1-3 in Chicago), featuring presentations on #lungcancer screening, targeted therapies, #SCLC & antibody drug conjugates. W/guests @ChristineBetv1 & Dr. Mohamed Abazeed. Listen: https://t.co/7TJnwzCh2R #LCSM https://t.co/2APT9KmxSj